Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J0841 · per 120 MG

Inj crotalidae im f(ab')2 eq

Products billed under this code include Anavip.

Payment limit per 120 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0841

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Anavip Rare Disease Therapeutics, Inc. 66621-0790-02 1 $1,084.909

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1,084.909 – 120 MG Inj crotalidae im f(ab')2 eq v1, posted September 17, 2026
1Q26 $4,925.16 +$3,880.01 120 MG Inj crotalidae im f(ab')2 eq v1, posted September 15, 2026
4Q25 $1,045.15 +$1.011 120 MG Inj crotalidae im f(ab')2 eq v1, posted September 8, 2026
3Q25 $1,044.139 +$0.592 120 MG Inj crotalidae im f(ab')2 eq v1, posted March 10, 2026
2Q25 $1,043.547 +$16.379 120 MG Inj crotalidae im f(ab')2 eq v1, posted March 10, 2026
1Q25 $1,027.168 −$12.946 120 MG Inj crotalidae im f(ab')2 eq v1, posted December 19, 2025
4Q24 $1,040.114 −$16.271 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 11, 2025
3Q24 $1,056.385 +$9.092 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 11, 2025
2Q24 $1,047.293 +$135.217 120 MG Inj crotalidae im f(ab')2 eq v1, posted March 11, 2025
1Q24 $912.076 −$201.435 120 MG Inj crotalidae im f(ab')2 eq v1, posted December 19, 2024
4Q23 $1,113.511 +$94.055 120 MG Inj crotalidae im f(ab')2 eq v1, posted October 10, 2024
3Q23 $1,019.456 +$586.266 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 5, 2024
2Q23 $433.19 −$553.812 120 MG Inj crotalidae im f(ab')2 eq v1, posted February 23, 2024
1Q23 $987.002 −$96.26 120 MG Inj crotalidae im f(ab')2 eq v1, posted December 6, 2023
4Q22 $1,083.262 +$11.05 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 22, 2023
3Q22 $1,072.212 +$153.366 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 9, 2023
2Q22 $918.846 −$103.599 120 MG Inj crotalidae im f(ab')2 eq v1, posted December 14, 2022
1Q22 $1,022.445 −$167.364 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 8, 2022
4Q21 $1,189.809 −$75.657 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 2, 2022
3Q21 $1,265.466 +$4.404 120 MG Inj crotalidae im f(ab')2 eq v1, posted June 2, 2022
2Q21 $1,261.062 −$2.429 120 MG Inj crotalidae im f(ab')2 eq v1, posted March 1, 2022
1Q21 $1,263.491 – 120 MG Inj crotalidae im f(ab')2 eq v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files